Evidence map›Paper›PMID 40156738›Full record

ArticleJapanese journal of radiology2025

Analysis of clinical factors associated with incomplete standard protocol

Shigeyasu Sugawara, Shozo Okamoto, Hirofumi Go, Shiro Ishii, Hiroshi Ito, Tohru Shiga, Noboru Oriuchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shigeyasu SugawaraAdvanced Clinical Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan. shige-s@fmu.ac.jp.ORCID http://orcid.org/0000-0002-8795-8099
Shozo OkamotoAdvanced Clinical Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.
Hirofumi GoAdvanced Clinical Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.
Shiro IshiiDepartment of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan.
Hiroshi ItoDepartment of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan.
Tohru ShigaAdvanced Clinical Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.
Noboru OriuchiAdvanced Clinical Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the clinical features of patients with neuroendocrine tumors (NETs) who could not complete the standard protocol (4 cycles of 7.4 GBq per 8 weeks) MATERIALS AND

methodsA retrospective single-center analysis was conducted on 26 patients who underwent

resultsThe clinical data of 24 patients with metastatic neuroendocrine tumors (NETs) were analyzed, of whom 16 patients completed the standard protocol

conclusionsIn this study, the presence of SRS-positive bone metastases and low hemoglobin levels were significant factors associated with the inability to complete

Indexed as

Neuroendocrine TumorsOctreotideOrganometallic CompoundsRadiopharmaceuticalsAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment Outcomelutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadiopharmaceuticals177Lu-DOTATATENeuroendocrine tumors (NETs)Peptide receptor radionuclide therapy (PRRT)Targeted radionuclide therapy (TRT)

Identifiers

PMID40156738
PMCPMC12287108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.